Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Neoplasms × tamibarotene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Promyelocytic, Acute 2 Leukemia, Myeloid, Acute 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Pancreatic Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 611 130-nm albumin-bound paclitaxel 173 Fluorouracil 168 Oxaliplatin 154 Albumin-Bound Paclitaxel 135 Capecitabine 120 Leucovorin 119 Irinotecan 103 Radiotherapy 88 Taxes 75 pembrolizumab 72 Cisplatin 69 Erlotinib Hydrochloride 64 Radiosurgery 59 Bevacizumab 50 Nivolumab 49 Cyclophosphamide 45 Magnetic Resonance Spectroscopy 41 Drug Therapy 41 folfirinox 37 Docetaxel 36 Cetuximab 36 S 1 (combination) 34 irinotecan sucrosofate 33 Specimen Handling 32 Paclitaxel 28 Biopsy 27 Radiation 26 durvalumab 22 Surgical Procedures, Operative 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05064618 2024-04-04

MIKE-1

Nagoya University

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡